GeneType Breakthrough for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Approved in Australia

Genetic Technologies Limited (GTG), a pioneering global leader in genomics-based tests focused on health, wellness, and the battle against serious diseases...

September 13, 2023 | Wednesday | News
Otsuka collaborates with ShapeTX to develop novel AAV gene therapies for ocular diseases

The companies will collaborate to apply ShapeTX’s AAVid™ capsid discovery platform and transgene engineering technology along with Otsuka&...

September 08, 2023 | Friday | News
Bristol Myers Squibb Signs $50M Deal to Address Immune-Mediated Diseases in Asia

US-based startup Zenas BioPharma has entered into a license and collaboration agreement with Bristol Myers Squibb Company to develop and commercialise ob...

September 07, 2023 | Thursday | News
Neurophet becomes the inaugural Korean firm selected by Roche Diagnostics for the Startup Creasphere APAC Program

Neurophet, an artificial intelligence (AI) solution company for brain disease, announced its participation in the global startup innovation program 'Startu...

September 06, 2023 | Wednesday | News
Sabin Institute Launches Global HPV Consortium in Malaysia to Prevent Cervical Cancer

“We are building a new ecosystem in global public health,” said Anuradha Gupta, President of Global Immunization at Sabin. “We aim to cre...

September 05, 2023 | Tuesday | News
ENHERTU® Earns Dual Breakthrough Therapy Designations for HER2-Expressing Cancers in the U.S

Designations for Daiichi Sankyo and AstraZeneca's ENHERTU include patients with HER2 expressing metastatic solid tumors and HER2 positive metastatic colo...

September 04, 2023 | Monday | News
ImmunoGen Teams Up with Takeda to Bring ELAHERE® to Japanese Market

ImmunoGen to Receive $34 Million1 in Upfront and Near-Term Milestone Payments and is Eligible to Receive Potential Regulatory and Commercial Milestone Paym...

August 29, 2023 | Tuesday | News
Malaysia Healthcare Travel Council Teams Up for "Rejuvenate with Malaysia Healthcare"

Malaysia Healthcare Travel Council (MHTC) is proud to announce a pilot programme, "Rejuvenate with Malaysia Healthcare," which aims to cultivate Malaysia a...

August 28, 2023 | Monday | News
Moderna Allocates $3 Million to Progress mRNA Therapeutics in Australia

Australia's Monash University and American firm Moderna have announced the establishment of the Monash-Moderna Quantitative Pharmacology Accelerator (MMQPA...

August 18, 2023 | Friday | News
TeleRobotic Stereotaxis Showcased at Asia Pacific Heart Rhythm Symposium

APHRS and the Society for Cardiac Robotic Navigation will host a joint session on September 2, 2023, during the APHRS annual congress. The joint session in...

August 17, 2023 | Thursday | News
Propanc Targets First Human Study Site at Peter Mac Cancer Center, Australia

The Peter Mac Cancer Center is a world leading cancer research, education and treatment center and Australia’s only public health service dedicated t...

August 16, 2023 | Wednesday | News
Hong Kong Department of Health has Approved the Registration Applications for the Uro-G and Uro-V Disposable Cystoscopic System

Uro-G offers a viewing angle of 120°, both 210° upward and 130° downward motion angles, and a 90° angle of rotation clockwise and countercl...

August 15, 2023 | Tuesday | News
Arcturus Therapeutics Partner ARCALIS Gets $115M Grants from Japan

LUNAR-FLU collaboration with CSL Seqirus achieves additional $17.5 million development milestone   Arcturus Therapeutics Holdings Inc. (the “C...

August 15, 2023 | Tuesday | News
China Pharma's Candesartan Hypertension Product Clears Generic Drug Evaluation

The consistency evaluation of generic drugs evaluates approved generic drugs based on the principle that generic drugs need to reach the same level of qual...

August 10, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close